Showing results (871-880 of 2,938) with videos related to
Sort By:
Pageof 294
Cancer Investigation|August 10, 2010
A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancerPing Tang, Jianmin Wang, David G Hicks, et al.Cancer Investigation|August 10, 2010
A phase II trial of vinflunine as monotherapy or in combination with trastuzumab as first-line treatment of metastatic breast cancerDenise A Yardley, Michael McCleod, Fred Schreiber, et al.Cancer Investigation|September 30, 2010
The oncotype DX recurrence score is correlated with a composite index including routinely reported pathobiologic featuresJoseph Geradts, Sarah M Bean, Rex C Bentley, et al.Cancer Investigation|September 30, 2010
Combination of phosphorylated and truncated EGFR correlates with higher tumor and nodal stage in head and neck cancerJames Keller, Kenneth R Shroyer, Shishir K Batajoo, et al.Cancer Investigation|September 30, 2010
Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: report of two cases and review of literatureGovardhanan Nagaiah, Mohammed Almubarak, Mudussara Khan, et al.Cancer Investigation|September 30, 2010
Statins use and risk for brain metastasis from lung cancerD Leigh, J Eken, J R Beal, et al.Cancer Investigation|September 30, 2010
Clinical significance of GPR56, transglutaminase 2, and NF-κB in esophageal squamous cell carcinomaTasneem Kausar, Rinu Sharma, Md Raghibul Hasan, et al.Cancer Investigation|May 21, 2010
Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esophageal cancer: a phase II studyMichele Orditura, Gennaro Galizia, Vincenzo Napolitano, et al.Cancer Investigation|April 17, 2010
ZBTB7 overexpression contributes to malignancy in breast cancerHongyan Qu, Danni Qu, Fuhui Chen, et al.Cancer Investigation|May 30, 2009
Taxanes in the adjuvant treatment of early breast cancer, emerging consensus and unanswered questionsShou-Ching TangPageof 294